ClinicalTrials.Veeva

Menu

Pericapsular Nerve Group Block: An Imaging Study for Determination of the Spread of the Injectate Using 3-D CT Scan

P

Philippe Gauthier

Status

Completed

Conditions

Mechanisms of Analgesia
Post Operative Pain

Treatments

Drug: 18 mL ropivacaine 0.5% + 2 mL radiopaque contrast
Procedure: Pericapsular nerve group block

Study type

Interventional

Funder types

Other

Identifiers

NCT06062134
2023-146

Details and patient eligibility

About

Over the last 20 years, different interventional regional analgesia techniques have been proposed to treat pain after hip surgeries.

The most commonly used techniques are the fascia iliaca and femoral nerve blocks, resulting in reduced pain scores, opioid-sparing effects, and opioid-related adverse effects. However, these interventional analgesia techniques result in a motor block and muscle weakness of the quadriceps muscle, impeding early ambulation and rehabilitation.

Recently, the pericapsular nerve group (PENG) block has been proposed as an effective choice for analgesia after hip surgeries while sparing the motor function of the lower extremities. The aim of this technique is to inject local anesthetic to target the more distal sensory branches innervating the anterior aspect of the hip joint.

Full description

Ten patients scheduled for hip surgery were included after Ethical Committee approval and informed consent were obtained.

Preoperatively, patients received an ultrasound-guided pericapsular nerve group block. The injections were performed preoperatively using a Canon US Applio 700 with a linear transducer (14 to 6 MHz), and a 21-gauge, 80 mm stimulating needle (SonoPlex Stim, Pajunk ® ️ GmbH, Germany). After confirmation of the correct needle tip position with 2 mL of sodium chloride 0.9%, 20 mL of injectate containing 18 mL ropivacaine 0.5% with 2 mL of radiopaque contrast (Iomeron 300: 61.24% w/v of Iomeprol equivalent to 30% iodine or 300 mg iodine/mL (Bracco UK Limited)) was injected.

After surgery, high-definition CT scans (Siemens) were obtained to determine the distribution patterns of the injectates.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. an indication for PENG blocks for postoperative pain management
  2. American Society of Anesthesiologists (ASA) physical status I or II
  3. at least 18 years old, and able to understand the purpose and risks of the study

Exclusion criteria

  1. pregnancy
  2. body mass index above 35 kg/m2
  3. hepatic or renal insufficiency
  4. history of allergic or adverse reactions to local anesthetics or contrast agents.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Pericapsular nerve group block group
Experimental group
Description:
All subjects enrolled in the study received a pericapsular nerve group block using a local anesthetic mixed with a contrast agent. After injection, subjects were transferred to the CT scan to obtain a 3D reconstruction to determine the spread of the injectate.
Treatment:
Procedure: Pericapsular nerve group block
Drug: 18 mL ropivacaine 0.5% + 2 mL radiopaque contrast

Trial contacts and locations

1

Loading...

Central trial contact

Angela Balocco, MD; Philippe Gautier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems